Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 900 of 2228 entries
View as:

A Dose Escalation Study of BIBF 1120 Together With Paclitaxel and Carboplatin in Patients With Advanced Stage Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02182232 Org: User:
Start: 06/30/05 End: - Due: -

Bioequivalence Study of UH-AC 62 XX Tablets Compared With the Capsule Formulations in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02181907 Org: User:
Start: 03/31/03 End: - Due: -

Relative Bioavailability BI 10773 and Metformin in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02172248 Org: User:
Start: 01/31/09 End: - Due: -

Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02211833 Org: User:
Start: 10/31/06 End: - Due: -

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Phase: N/A Priority: Normal
NCT ID: NCT00153101 Org: User:
Start: 11/30/01 End: - Due: -

Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia

Phase: N/A Priority: Normal
NCT ID: NCT02244268 Org: User:
Start: 10/31/00 End: - Due: -

Trial to Determine the Comparability of Ipratropium Bromide Hydrofluoroalkane (HFA)-134a Inhalation Aerosol to ATROVENT® Chlorofluorocarbon (CFC) Inhalation Aerosol, in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02236169 Org: User:
Start: 10/31/00 End: - Due: -

A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01243268 Org: User:
Start: 12/21/10 End: 08/18/16 Due: 08/18/17

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 201335 as Softgel Capsule in Naive Hepatitis C Virus (HCV) Patients

Phase: N/A Priority: Normal
NCT ID: NCT00947349 Org: User:
Start: 07/31/09 End: 08/31/11 Due: 08/31/12

A Study to Test How Iclepertin is Taken up in the Blood of People With and Without Kidney Problems

Phase: N/A Priority: Normal
NCT ID: NCT05718843 Org: User:
Start: 02/01/23 End: 10/24/23 Due: 10/24/24

This Study in Healthy Men Tests How Different Doses of BI 1265162 Are Taken up in the Body and How Well They Are Tolerated.

Phase: N/A Priority: Normal
NCT ID: NCT03576144 Org: User:
Start: 07/11/18 End: 12/06/18 Due: 12/06/19

Effects of Steady-state TPV/RTV on the Single-dose Pharmacokinetics of Rifabutin and the Effects of Single-dose Rifabutin on the Steady-state Pharmacokinetics of TPV in Healthy Adult Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02251171 Org: User:
Start: 08/31/03 End: - Due: -

Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00281567 Org: User:
Start: 08/31/02 End: - Due: -

Compare Safety and Efficacy of BIBF 1120 Versus Sunitinib.

Phase: N/A Priority: Normal
NCT ID: NCT01024920 Org: User:
Start: 12/16/09 End: 06/19/20 Due: 06/19/21

A Study in Healthy Men to Test Whether Food Influences the Amount of BI 3731579 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT06861829 Org: User:
Start: 03/19/25 End: 04/23/25 Due: 04/23/26

Anticoagulant Utilization Pattern

Phase: N/A Priority: Normal
NCT ID: NCT01847560 Org: User:
Start: 04/17/13 End: 11/01/17 Due: 11/01/18

Relative Bioavailability of Dabigatran and Atorvastatin in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02171039 Org: User:
Start: 06/30/06 End: - Due: -

A Study to Test How Different Doses of BI 685509 Are Tolerated in Patients With Liver Problems

Phase: N/A Priority: Normal
NCT ID: NCT03842761 Org: User:
Start: 03/06/19 End: 05/20/21 Due: 05/20/22

Pharmacokinetics and Safety of BILR 355 in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02253940 Org: User:
Start: 10/31/06 End: - Due: -

Study to Investigate Safety and Tolerability of BI 1744 CL in Free Dose Combination With Tiotropium Bromide Both Administered by Respimat® in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02259946 Org: User:
Start: 04/30/06 End: - Due: -

Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02204059 Org: User:
Start: 12/31/99 End: - Due: -

Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2

Phase: N/A Priority: Normal
NCT ID: NCT01662986 Org: User:
Start: 08/01/12 End: 04/01/14 Due: 04/01/15

This Study in Healthy Men and Women Tests Whether BI 409306 Has an Effect on the ECG (Thorough QT Study)

Phase: N/A Priority: Normal
NCT ID: NCT03934203 Org: User:
Start: 05/09/19 End: 09/06/19 Due: 09/06/20

A Study in Healthy Humans to Assess the Relative Bioavailability of One Fixed-dose Combination Tablet Empagliflozin/Metformin Versus Jardiance® Tablet and Glifage® Tablet Administered Together

Phase: N/A Priority: Normal
NCT ID: NCT05083949 Org: User:
Start: 07/23/21 End: 09/09/21 Due: 09/09/22

Tiotropium/Salmeterol Inhalation Powder in COPD

Phase: N/A Priority: Normal
NCT ID: NCT00668772 Org: User:
Start: 04/15/08 End: 11/21/08 Due: 11/21/09